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Abstract—We present HYDRA: a multi-agent hybrid diagnosis
and monitoring architecture that is aimed at helping diabetic
patients manage their illness. It makes use of model-based
diagnosis techniques, where the model can be developed by
two different approaches combined in a novel way. In the first
approach, we build the model based on the medical guidelines
provided for diabetes. A computational logic agent monitors the
patient and provides feedback based on the model whenever the
current observations regarding the patient are sufficient to draw
a conclusion. In the second approach, we assume a function
for the model, and learn its parameters through data. The
model is consistently updated via incoming observations about
the patients, and allows prediction of possible future values. We
describe the components of such an architecture, and how it
can integrated into the existing COMMODITY12 personal health
system. We implement a prototype of HYDRA, and present its
workings on a case study on hypoglycemia monitoring. We report
our prediction results for this scenario.
I. INTRODUCTION
Diabetes is defined as a group of metabolic diseases in
which a patient has high blood-sugar, either due to the pancreas
failing to produce enough insulin, or because cells do not
respond to insulin as expected [1]. Two of the most important
short-term complications of diabetes are hypoglycemia and
hyperglycemia (very low and high blood glucose; respec-
tively), both of which are life-threatening. The management
of diabetes is becoming an increasingly important problem
worldwide with recent efforts aiming at controlling the afore-
mentioned short-term complications [2], [3], [4]. The normal-
isation of blood glucose is one of the parameters that must
be monitored by a personal health system according to a
formal model of the disease (i.e., medical guidelines). This
is especially important for Type 1 diabetic patients, who need
to have their glucose levels monitored continuously.
In this work, we are motivated by our participation in
the COMMODITY12 personal health system, which focuses
on giving diabetic patients medical advice to maintain their
illness through the use of sensors and artificial intelligence
agents [5]. Currently, we measure glucose levels through the
use of two different sensors: (i) the finger prick method via
the GlucoTel sensor1 suitable for everyday use, and (ii) the
continuous glucose monitor CGM2 to be implanted on the
side of the abdomen and worn for 3 to 5 days continuously.
1http://www.bodytel.com
2http://www.medtronicdiabetes.com/products/guardiancgm
In the near future, continuous monitoring of glucose will also
be relevant for Type 2 diabetic patients as new technology
becomes available to effortlessly measure blood glucose (e.g.,
smart contact lenses).
Currently, glucose monitoring in COMMODITY12 is per-
formed based on expert systems like logic-based rules, that
represent recent medical expertise in diabetes management.
The measured glucose value is fed into the system, and if
any of the rules fire (e.g., a hypoglycemia situation where
the glucose value is less than 3 mmol/l), then an alert is
created. While this is very helpful for the patient, a personal
health system should be able to assist in situations where the
rules cannot make a conclusive decision. For example, if the
measured value is 3.1, the rules would assume everything is
under control. However, due to some noise in the sensor, the
value might be misread and the patient’s situation might get
worse if we wait for another measurement. Our motivation in
this paper is to deal with such situations, and try to predict
whether a measured value of 3.1 may lead to a hypoglycemia.
Accordingly, we propose a multi-agent hybrid diagnosis
and monitoring architecture for diabetes called HYDRA. We
build upon existing work on COMMODITY12, and extend
its current diagnosis architecture with machine learning based
prediction. We extend the guidelines to allow more customised
and flexible management of patient’s glucose values by giv-
ing advice in situations which are not considered critical.
We present a novel way of combining the two model-based
approaches, in which the model is described in a different
manner. In the current version of COMMODITY12, the model
is represented by a logic based system that reflects the med-
ical guidelines for diabetes. In the proposed extension, the
parameters of the model are rather learnt through data and
consistently updated (customised) with data regarding each
patient. We present the details of such a hybrid architecture.
Moreover, we implement a prototype of HYDRA using the
GOLEM agent platform [6], and present a case study on
hypoglycemia monitoring. We show that our system achieves
promising prediction results on synthetic data.
The rest of the paper is structured as follows. Section II
reviews the COMMODITY12 architecture and related work
on blood glucose prediction. Then, Section III describes our
proposal to extend the current diagnosis system with a pre-
diction component. Section IV presents a case study using
continuous glucose data and shows our results. Finally, Section
V concludes the paper and presents possible future directions.
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Fig. 1. Current architecture of the COMMODITY12 PHS. The monitoring
agent makes a decision based on the medical guidelines and the current
situation of the patient.
II. BACKGROUND & RELATED WORK
A. COMMODITY12 Personal Health System
Figure 1 describes the current diagnosis architecture of
COMMODITY12. In this paper, we focus on the workings of
the monitoring agent, rather than describing every component
of the system (e.g., sensors). 
select(monitor_glucose, alert(Patient, hypoglycemia), T):-
holds_at(glucose(Patient)=Value, T),
Value < 3. 
Listing 1. Rule for sending a hypoglycemia alert. The rule is given in Prolog
syntax and can be read as follows: while trying to monitor glucose, select the
action to alert the patient of a hypoglycemic attack if the patient’s current
glucose value is less than 3. The predicate holds at/2 is implemented in the
Event Calculus [7], a logic-based formalism that is used to handle temporal
conditions in the body of the rules.
The monitoring agent uses computational logic to decide an
action that reflects the current situation of the patient, e.g., send
an alert if recent glucose levels are low (hypoglycemia). It uses
medical guidelines represented as logic rules and any relevant
profile information about the patient’s medical background.
Listing 1 shows the rule for selecting a hypoglycemia alert.
Glucose measurements are received by the agent in the form
of observation events. When a new observation event comes,
the agent checks the corresponding glucose value and produces
an alert if the value is below the certain threshold.
B. Glucose Prediction
For prediction of continuous signals such as blood glucose,
we combine ideas from fields such as data-driven model-based
diagnosis and time series analysis. Flesch and Lucas map
the process of model-based diagnosis to the formalisation of
Bayesian networks [8]. This work is related to the proposal
presented in this paper as one can read (switching) Kalman
filters as dynamic Bayesian networks. They describe static
boolean models only, whereas we allow also time series and
hybrid models of continuous and discrete valued data. There
is a number of studies that deploy data-driven models and
machine learning for prediction, diagnosis, clinical decision
making and other health-care related topics. Recently, diverse
uni-variate and multi-variate models that are related to Kalman
filters have been used in continuous glucose monitoring and
hypoglycemia prediction [9], [10], [3]. They differ from our
proposal since they consider fixed parameters of variables (i.e.,
chosen by an expert investigator).
Knobbe and Buckingham apply the extended Kalman filters
for continuous glucose monitoring [2]. Here, the standard
Kalman filters equations are extended with a non-linear process
function to capture non-linear dynamics in the data. This can
lead to higher performance, but the structure of this non-linear
function has to be determined via trial and error and fine-tuning
by the researcher. An online-learning method was proposed by
Eren et al. [11]. They deploy a recursive least square method to
learn an extended autoregressive moving average model, taking
into account exogenous input within a multi-variate manner.
This exogenous input is unknown until new variables become
available. Taking additional variables for their dynamic system
shows similarity with our work. However, it is hard to establish
a connection to model-based diagnosis in this context, because
there is no latent root in the topology of the underlying model
that can be utilised as diagnostic input variable. Turksoy et
al. have used Kalman filters and SavitzkyGolay filter for de-
noising and trained an autoregressive moving average model
with some background information for prediction, which leads
to early alarm of hypoglycemia [4].
III. HYDRA ARCHITECTURE
A. Multi-agent Architecture
Figure 2 describes how we propose to extend the current
diagnosis architecture of COMMODITY12. First, we focus on
the right part of the figure and introduce our prediction agent.
The prediction agent relies on a prediction model, where the
parameters of the model are learnt from the training data stored
in the patient database. Once the model is trained, the agent
is ready to make predictions about future glucose values.
Now, we come back to our monitoring agent and describe
how we have extended its rule-base to enable the prediction
capability. The rule given in Listing 1 is still valid, and any glu-
cose measurement that is considered critical is corresponded
with an alert. In addition, the monitoring agent decides whether
to request a prediction from the prediction agent. Listing 2
shows the rule for deciding this prediction request. When this
request is received, the prediction agent responds with the next
glucose value that is predicted based on the learnt model. 
select(monitor_glucose,ask(Ag,glucose(Patient)=NextVal),T):-
predictor(Ag),
holds_at(glucose(Patient)=Value,T),
Value >= 3,
Value < 4. 
Listing 2. Rule for requesting a prediction.
Note that the monitoring agent sends every received ob-
servation to the prediction agent together with any relevant
profile information (e.g. the patient makes excessive use of
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Fig. 2. Proposed extension with the addition of a prediction agent. The prediction agent learns the model parameters from a training dataset. Every incoming
value from the monitoring agent about a patient is used to update the model specific to that patient.
alcohol or works evening shifts). These are used in turn to
update the prediction model and customise it for that specific
patient in order to increase prediction performance.
B. Prediction Component
For the prediction component, we deploy a framework for
reasoning about observations over time by building upon the
existing state-of-the-art in time-series analysis and machine
learning techniques for prediction. Note that prediction should
be read in a temporal sense: we want to predict future values of
glucose. The component is motivated by ideas of the classical
model-based diagnosis literature. The classical definition of
model-based diagnosis entails the identification of causes for
a set of symptoms [12], given a description (e.g. a logical
theory) of a system comprised of components and some obser-
vations [13]. The complexity of the human organism prohibits
us from providing such a description of every single process
underlying a symptom or an observation, that is a measured
glucose value. We need to model some of the underlying
physical processes and the affected components without any
knowledge about them. In machine learning, such components
are called hidden or latent [14]. The method should also be able
to take input from a logical theory. If the rule-based model used
by the monitoring agent diagnoses a condition which affects
the observed glucose values, then the prediction model should
take this information into account.
We can thus summarise three requirements for our predic-
tion model. It should support:
• prediction of future glucose values;
• hidden components;
• a hierarchical structure, with a variable on top that is
either Boolean or categorical.
These requirements define our hierarchical hidden struc-
ture. This hidden structure has a categorical (discrete-valued)
hidden variable at the top of the hierarchy. It models the nature
and cause of a series of observations, which is what we want
to detect with model-based diagnosis. ‘Hidden’ does not mean
we are inhibited from diagnosing a cause by a doctor or with
the logic based component - we simply assume it to be hidden
during the training of the model and add the information on
the hidden state for prediction if necessary. We can interpret
the entire hidden structure as the underlying process which
cannot be observed but which is generating measurable and
therefore observable outcomes.
To reflect the state-of-the-art in glucose management, we
choose a switching Kalman filter (SKF) [15], because it
subsumes models used in the current machine learning-based
glucose management approaches (for example see [10], [3],
[16]). Furthermore, its model structure provides the desirable
hidden properties described in the requirements above (see
Figure 3). It interfaces with model-based diagnosis in the
sense that we replace the logical theory representing the
domain by a machine learning approach that relies on a
statistical theory applied in the same domain. For example,
imagine two patients both suffering from Diabetes type 2.
One is diagnosed with alcoholism and one is not. Here, we
can assume a two-state switch for our Kalman filter model.
(alcoholism = {true, false}). This is our statistical theory.
We can also imagine more than one variable involved leading
to multiple states possible instead of two.
We deploy the SKF in two stages. In an offline training
stage, we learn the parameters of the model that define its
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Fig. 3. Graphical representation of a switching Kalman filter. Hidden
variables are depicted with no filling, observed ones are grey. We sketch
discrete-valued variables as square nodes and continuous-valued ones as
circular nodes. The origin of the data generating model is a discrete state
variable s. For example, if the state variable s is some co-morbidity of diabetes
at time t, we would expect the observations to differ depending on whether
or not a patient is suffering from this co-morbidity.
linear transformations and error distributions given a set of
training data. Then, in an online stage, we update the hidden
variables using the process model with learned parameters.
A simple linear transformation provides us with a Gaussian
mixture probability distribution of next observation. With a
technique called moment matching we then compute the next
observation with maximum likelihood. The details of the above
stages we omit, but we refer the interested reader to the work
presented by Murphy in [15].
C. Implementation
HYDRA requires that a monitoring agent and a predictor
agent communicate with each other and the user using a
request-reply protocol. The monitoring agent must be devel-
oped using declarative logic-based tools and techniques such
as those characteristic of Prolog development environments.
On the other hand, the prediction agent requires mathematical
problem solving and number crunching to implement the tech-
niques required behind SKF, which can be suitably supported
with either Java or Matlab technologies.
To support the HYDRA requirements above, we have im-
plemented our prototype using the GOLEM agent platform
[6]. GOLEM is a logic-based agent platform developed to
support multi-agent system environments that evolve over time.
It provides a middleware that agent developers can use to
build multi-agent systems using either Java and Prolog, which
meets our requirements. The platform also allows the devel-
opment of objects, that can wrap different types of entities,
from databases to external functionalities provided by external
components like Matlab.
Using GOLEM, the reasoning component of the monitoring
agent is programmed using Prolog tools and techniques, while
all other (low-level) functionality throughout the system (e.g.,
communication between agents, processing of measurement
data) is implemented in Java. The actual prediction component
is implemented in Matlab and wrapped as a Java object that is
used by the prediction agent. The prediction component keeps
a separate copy of the prediction model for each patient, and
acts as a service to respond queries from the monitoring agent.
GOLEM allows the monitoring and prediction agents to be
run on different physical machines to improve performance
and allow scalability. For the sake of experimentation, the
prediction component can serve one request at a time (i.e.,
a single thread) in the current prototype.
IV. CASE STUDY: HYPOGLYCEMIA MONITORING
In this case study, we present the workings of the HY-
DRA architecture on continuous glucose monitoring. More
specifically, we are looking for cases of a medical emergency
regarding the blood glucose level of the patient known as
hypoglycemia. Hypoglycemia is formally described by the
International Classification of Diseases as the patient’s glucose
level being below a certain threshold value. It can produce a va-
riety of symptoms and effects but the principal problems arise
from an inadequate supply of glucose to the brain, resulting in
impairment of function. Effects can range from mild dysphoria
to more serious issues such as seizures, unconsciousness, and
(rarely) permanent brain damage or death. According to the
severity level of hypoglycemia, a series of actions may need
to be taken immediately, including alerting the doctor of the
patient.
Conventional glucose monitoring usually relies on guide-
lines that provide specific thresholds and constraints for hypo-
glycemia. If we only implemented the rules that represent the
guidelines literally, then if a patient’s glucose measurement
is slightly greater than 3 mmol/l, then no alert should be
sent to the user. Still, for some doctors this would still be an
alarming measurement. We therefore extend the conventional
monitoring of hypoglycemia with the addition of our prediction
component. In particular, we aim at providing the patient
and medical personnel alike with additional information, even
though the current glucose level of the patient is not at a
critical level. Our system continuously reads glucose data as
they become available, and takes actions based on the patient’s
current measurement as well as updating the prediction model
specific to that patient.
To test our prediction agent and the HYDRA architecture,
we work with synthetic data generated with auto-regressive
models. The justification behind this choice is two-fold: (i)
we are not aware of any open data set providing continuous
glucose data suitable for our system, (ii) we are currently per-
forming clinical trials on patients in COMMODITY12, which
will lead to data from a continuous glucose measurement
device. Whenever the measuring device is activated, we will
be able to read glucose measurements every five minutes from
diabetic patients. However, this data is not yet available in the
COMMODITY12 project.
Listing 3 shows sample output of HYDRA for each possible
outcome of monitoring. Note that the glucose values shown
are not from consecutive measurements. When the glucose
measurement is above 4mmol/l, the system takes no action as
we are only dealing with cases of hypoglycemia here. When
the glucose level drops below 4 mmol/l (but still not at a
critical level), the system makes a prediction for the next
possible value based on the customised prediction model for
the patient. Finally, if the glucose level is critical (i.e., < 3
mmol/l), the system sends out an alert.
Figure 4 illustrates a period of time in the data where
our approach becomes useful. We start with an actual glucose
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Fig. 4. Glucose level prediction for the next 30 min based on the currently
measured value. Straight line shows the actual measured values (red circles),
whereas the dashed line shows the predicted values (green circles).
measurement of 3.3 mmol/l, and predict the glucose trend
of the patient for the next half an hour (i.e., a total of six
values for every five minutes). Note that the straight line shows
the actual trend of the patient’s glucose level, which is going
towards a hypoglycemia situation in the next 15 minutes. The
dashed line shows our prediction for the next 30 minutes,
and it successfully catches the patient’s glucose trend for the
given period. Moreover, the first point in time where the actual
hypoglycemia occurs is captured in our prediction (the 15
minute mark). Therefore, we can use this information to alert
the patient 15 minutes before the actual hypoglycemia occurs.
 
MA receives observation: obs(glucose,4.28)
MA sends request for model update
<<< NO ACTION >>>
PA updates model
MA receives observation: obs(glucose,3.30)
MA sends request for model update
MA calls predictor
PA sends prediction
PA updates model
<<< PREDICTION 3.03 >>>
MA receives observation: obs(glucose,2.78)
MA sends request for model update
<<< HYPO ALERT >>>
PA updates model 
Listing 3. Sample output of HYDRA. MA and PA stand for the monitoring
and prediction agents; respectively.
Prediction Performance
We test the predictive component by assuming three dif-
ferent states and corresponding time series. We create each of
these time series using auto-regressive models. Auto-regressive
models are indeed a good choice, since some instances of
this model class have been declared suitable to model glucose
curves [16]. For illustrating and testing the inference and
learning capabilities of the switching Kalman filters algorithm,
we implement three second-order auto-regressive models:
yt = φ1yt−1 + φ2yt−2 + et (1)
where yt are the observations we make at time t and et is a
zero-mean Gaussian noise/error term:
et ∼ N (0, σ). (2)
The auto-regressive models differ with regards to the choice of
the parameters θ = {φ1, φ2, σ} (where we assume for each si a
different set θ). Here, we assume that each different time series
was “created” by a different underlying state s. We form one
combined time series by connecting these three separate time
series. The combined time series has a length of 600 points
in time (200 time points per auto-regressive model). We try to
initialise these parameters in a way that they resemble glucose
values as closely as possible.
To provide an initial performance evaluation, we assume
that the monitoring agent provides some profile information on
the current state of the patient that produces the observations.
Then, we create the next observation at T +1 = 601 given the
true generative system that creates our data. We compare this
actual value with the value predicted by our model.
We run the above procedure 80 times resulting in a root
means square error of 0.02 mmol/l for predicting the next
observation. This would correspond to five minutes ahead
of time with real continuous glucose data. Note that this
very promising result needs to be considered in the following
context. Firstly, a five minute prediction range is not very
large compared to the standard glucose management literature.
However, given the way the component is integrated in the
agent architecture this is not of great importance. Secondly,
the result is based on synthetic values and needs to be verified
with real world values as well.
V. DISCUSSION
We have presented HYDRA: an agent-based hybrid diagno-
sis and monitoring architecture for diabetes. The monitoring
agent uses computational logic to draw conclusions based
on patient’s current situation. When the observed data is
not adequate to make a decision (using the conventional
guidelines), the prediction agent is consulted to come up
with anticipated possible future observations. Such predicted
observations make use of state-of-the-art machine learning
techniques using switching Kalman filters.
We have developed a prototype of the system in the
GOLEM agent platform, making use of the advantages pro-
vided by different programming paradigms supported: the low-
level functionality of the system is implemented procedurally
(in Java) to support efficiency and easy integration with a
distributed environment, the monitoring agent is implemented
declaratively (in Prolog) to support explanation to the user,
and the prediction agent is implemented in Matlab to provide
ease of the mathematical processing expected. We have tested
the system on continuous glucose data, and presented our
prediction results.
We have also shown how our system can be used to support
decisions on observations (measurements) that are borderline.
In such situations, we rely on the use of the predictor agent
to report on any trends of future measurements that may
have undesirable effects with the patient’s monitoring. Such a
feature can complement the conclusions from guidelines that
may be deemed to be too ”black and white”, as for example we
saw with the situation where the glucose level is 3.3 mmol/l.
Such a predictive capability can be very useful to doctors who
might want to complement their decisions on these borderline
observations with evidence from existing patient data.
There are several diagnosis / prediction architectures in
the literature that deal with medical data. Recently, Lu et al.
implemented a system consisting of wavelet-transform and a
hidden Markov model for diagnosing heart diseases [17]. They
apply state of the art de-noising in context of a dynamical
system. However, they do not connect their work with classical
model-based diagnosis approaches as we do here.
The problem of medication adherence in type 2 diabetes
patients has been tackled with data-driven methods [18]. Here,
evidence-based decision support systems were enhanced by
machine learning techniques. The authors cluster the data into
a mixture of Gaussians. Clusters were related to patient’s
demographic and treatment characteristics. Then, they learn
logistic regression functions and artificial neural networks to
classify adherence and non-adherence behaviour. In contrast,
we combine the two steps in one, since switching Kalman
filters can be seen as a moving Gaussians over time.
Oberkampf and colleagues include different sources of
knowledge into a diagnostic method for ranking the likelihood
of given diseases [19]. Similar to the work presented here,
the ranking framework starts from a symbolic logic point of
view motivated by logical knowledge openly available such as
SNOMED. However, their probabilistic component is defined
in terms of a weighted logic and do not include state-of-the-art
machine learning methods as we do here.
We plan to extend work presented in this paper in the fol-
lowing directions. We will evaluate the prediction component
with real world data in the COMMODITY12 project and we
will extend the monitoring to other continuous signals such as
heart rate. Rather than using predefined threshold values for
initiating a prediction (e.g., between 3 and 4), we will learn
these values which might vary from patient to patient. We
believe that this will lead to better efficiency for the overall
system. We will also develop a web-based GUI for HYDRA and
allow users to train models with their own data. We will further
revise the prototype, in particular, the prediction component as
a multi-threaded service, to make it scalable.
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